Suntrust Banks’s NovoCure NVCR Stock Holding History

Suntrust Banks’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$597K	Sell	7,988 -1,318	-14%	-$105K	﹤0.01%	894
2019 Q2	$589K	Buy	9,306 +65	+0.7%	+$3.29K	﹤0.01%	923
2019 Q1	$446K	Sell	9,241 -215	-2%	-$10.3K	﹤0.01%	971
2018 Q4	$317K	Sell	9,456 -4,272	-31%	-$156K	﹤0.01%	1031
2018 Q3	$719K	Buy	13,728 +821	+6%	+$32.7K	﹤0.01%	810
2018 Q2	$404K	Buy	+12,907	New	+$359K	﹤0.01%	998

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Suntrust Banks's NVCR Position: Q3 2019 in Review

Suntrust Banks reduced its NovoCure (NVCR) stake by 14% in Q3 2019, selling an estimated $105K and leaving 7,988 shares worth $597K. The position accounts for ﹤0.01% of the portfolio, ranked #894.

Suntrust Banks first reported a position in NVCR in Q2 2018 and has held it in 6 quarters since. The position peaked at $719K in Q3 2018. 240 funds tracked by Wall St. Rank hold NVCR as of Q3 2019.

Suntrust Banks held 7,988 shares of NovoCure worth $597K as of Q3 2019.
Suntrust Banks sold 1,318 NovoCure shares in Q3 2019, an estimated $105K.
NovoCure made up ﹤0.01% of Suntrust Banks's portfolio in Q3 2019, its #894 holding.
Suntrust Banks first reported a position in NovoCure in Q2 2018 and has held it in 6 quarters since.
Suntrust Banks's NovoCure position peaked at $719K in Q3 2018.
240 funds tracked by Wall St. Rank held NovoCure as of Q3 2019.

Based on Suntrust Banks's 13F filing for Q3 2019, filed 12 Nov 2019.